Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Encora Therapeutics Tremor Reduction Device
Locations
1
United States
Encora Therapeutics
Cambridge, Massachusetts, United States
Start Date
January 1, 2024
Primary Completion Date
July 3, 2024
Completion Date
November 12, 2024
Last Updated
October 1, 2025
NCT07428447
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
Lead Sponsor
Encora, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions